Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Mississippi · 2026 Regular Session · Bill

HB 314: Ibogaine; authorize SDH to select a consortium to conduct a drug development clinical trial with, to secure FDA's approval of.

Enacted Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

HB 314 is a bill introduced in the Mississippi House on January 8, 2026. According to its official title, it concerns: Ibogaine; authorize SDH to select a consortium to conduct a drug development clinical trial with, to secure FDA's approval of. Primary sponsor: Sam Creekmore (Republican). It lists 3 additional sponsors. Most recent recorded action (March 26, 2026): Approved by Governor.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Sponsors

Sponsors by party (alphabetical): Republican 4

NameRolePartyChamberDistrict
Sam CreekmorePrimary sponsorRepublicanHouse14
Tracy ArnoldCo-sponsorRepublicanHouse3
Larry ByrdCo-sponsorRepublicanHouse104
Bubba CarpenterCo-sponsorRepublicanHouse1

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Approved by Governor
  2. Enrolled Bill Signed
  3. Enrolled Bill Signed
  4. Concurred in Amend From Senate
  5. Returned For Concurrence
  6. Passed As Amended
  7. Amended
  8. Reconsidered
  9. Motion to Reconsider Entered
  10. Passed As Amended
  11. Amended
  12. Title Suff Do Pass

Showing 12 most recent of 17 actions. Full history

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source